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1. Introduction 
1.1 Lipoxygenase – definition, structure, reaction mechanism and metabolic functions 
Lipoxygenases (EC 1.13.11.12, linoleate:oxygen, oxidoreductases, LOXs) which are widely 
found in plants, fungi, and animals, are a large monomeric protein family with non-heme, 
non-sulphur, iron cofactor containing dioxygenases that catalyze the oxidation of 
polyunsaturated fatty acids (PUFA) as substrate with at least one 1Z, 4Z-pentadiene 





Fig. 1. Lipoxygenase substrates, linoleic, -linolenic and arachidonic acid. 
                                                 
*1 Laboratory of Animal Biology, National Research Development Institute  
for Animal Biology and Nutrition Baloteşti (IBNA), Romania 
2 Faculty of Environmental Protection, University of Oradea, Romania 
3 Department of Chemistry and Biochemistry, University of Agricultural Sciences and Veterinary Medicine Cluj-
Napoca, Romania 
4 Department of Life Science and Biotechnology, Faculty of Life and Environmental Science, Shimane University, 
Japan 






The crystal structures of soybean LOX-1 (Minor et al., 1996), LOX-3 (Skrzypczak-Jankun et al., 
1997), rabbit 15S-LOX-1 (Gillmor et al., 1997), and coral 8R-LOX (Oldham et al., 2005) have 
been elucidated thus far and has helped in understanding the properties of LOXs at the 
molecular level. Several structures of soybean LOX in complex with its product or inhibitor are 
also known (Skrzypczak-Jankun et al., 2001; Skrzypczak-Jankuna et al., 2003; Skrzypczak-
Jankunb et al., 2003; Borbulevych et al., 2004; Skrzypczak-Jankun et al., 2004). There are 
significant differences in size, sequence, and substrate preference between the plant and 
animal LOXs, but the overall folding and geometry of the nonheme iron-binding site are 
conserved (Kühn et al., 2005; Skrzypczak-Jankun et al., 2006). All LOXs are folded in a two-
domain structure that is composed of a smaller -barrel domain (N-terminal domain) and a 
larger -helical catalytic domain (C-terminal domain) (Choi et al., 2008). The nonheme iron 
essential for activity is positioned deep in a large cavity that accommodates the substrate (Choi 
et al., 2008). The regio- and stereospecificities of the various LOX isozymes are believed to be 
determined by the shape and depth of the cavity as well as the binding orientation of the 
substrate in the cavity (Borngräber et al., 1999; Kühn, 2000; Coffa et al., 2005). 
The initial step of LOX reaction is removal of a hydrogen atom from a methylene unit 
between double bonds in substrate fatty acids (Fig. 2A). The resulting carbon radical is 
stabilized by electron delocalization through the double bonds. Then, a molecular oxygen is 
added to the carbon atom at +2 or –2 position from the original radical carbon, forming a 
peroxy radical as well as a conjugated trans, cis-diene chromophore. The peroxy radical is 
then hydrogenated to form a hydroperoxide. The initial hydrogen removal and the 
following oxygen addition occur in opposite (or antarafacial) sides related to the plane 
formed by the 1Z, 4Z-pentadiene unit. In most LOX reactions, particularly those in plants, 
the resulting hydroperoxy groups are in S-configuration, while one mammalian LOX and 
some marine invertebrate LOXs produce R-hydroperoxides. Even in the reactions of such 
“R-LOXs”, the antarafacial rule of hydrogen removal and oxygen addition is conserved 
(Chedea & Jisaka, 2011). 
In cases of plant LOXs, including soybean LOXs, the usual substrates are C18-
polyunsaturated fatty acids (linoleic and -linolenic acids), and the products are their 9S- or 
13S-hydroperoxides (Fig. 2B). Most plant LOXs react with either one of the regio-specificity, 
while some with both. Therefore, based on the regio-specificty, plant LOXs are classified 
into 9-LOXs, 13-LOXs, or 9/13-LOXs (Chedea & Jisaka, 2011).  
  
Fig. 2. LOX reaction showing the principal steps of LOX reaction (Panel A), and the actual 
reactions of plant LOXs and -linolenic acid (Panel B). HPOTE: 
hydroperoxyoctadecatrienoic acid (Chedea & Jisaka, 2011). 
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Theorell et al. (1947) succeeded in crystallizing and characterizing lipoxygenase (LOX) from 
soybeans and since then among plant LOXs, soybean LOX-1 can be regarded as the 
mechanistic paradigm for these nonheme iron dioxygenases (Coffa et al., 2005; Minor et al., 
1996; Fiorucci et al., 2008).  
LOX isoenzymes of soybean seed are 94–97 kDa monomeric proteins with distinct isoelectric 
points ranging from about 5.7 to 6.4, and can be distinguished by optimum pH, substrate 
specificity, product formation and stability (Siedow, 1991). LOX-1 is the smallest in size (838 
amino acids; 94 kDa), exhibits maximal activity at pH 9.0, and converts linoleic acid 
preferentially into the 13-hydroperoxide derivative. LOX-2 is characterized by a larger size 
(865 amino acids; 97 kDa), by a peak of activity at pH 6.8, and forms equal amounts of the 
13- and 9-hydroperoxide compounds (Loiseau et al., 2001). LOX-2 oxygenates the esterified 
unsaturated fatty acid moieties in membranes in contrast to LOX-1 which only uses free 
fatty acids as substrates (Maccarrone et al., 1994). LOX-3 (857 amino acids; 96.5 kDa) exhibits 
its maximal activity over a broad pH range centred around pH 7.0 and displays a moderate 
preference for producing a 9-hydroperoxide product. It is the most active isoenzyme with 
respect to both carotenoid cooxidation and production of oxodienoic acids (Ramadoss, 
1978). 
Arachidonic acid metabolism by LOX in platelets was demonstrated in 1974 (Hamberg & 
Samuelsson, 1974). Rabbit reticulocyte LOX was described for the first time in 1975 (Schewe 
et al., 1975). There are 6 functional LOXs in humans: 5-LOX; 12/15-LOX (15-LOX-1); 
platelet-type 12-LOX; 12R-LOX; epidermis-type 15-LOX (15-LOX-2); and epidermis-Alox3. 
Each of these genes expresses a catalytically active enzyme except epidermis-Alox3, which 
encodes an enzyme that has hydroperoxidase activity. Thus, the main LOX enzymes with 
fatty acid oxygenase activity found in humans are 5-LOX, 15-LOX-1, 15-LOX-2, platelet-type 
12-LOX and 12R-LOX (Bhattacharya et al., 2009). 
In their review concerning the metabolic functions of LOX, Ivanov et al. (2010) present two 
aspects of LOX biology: (i) 30 years ago, leukotrienes generated by 5-LOX were identified as 
potent pro-inflammatory mediators (Samuelsson et al., 1980; Jakschik & Lee, 1980). Since 
then, additional pro-inflammatory products have been discovered (Feltenmark et al., 2008). 
On the other hand, anti-inflammatory and/or pro-resolving lipids generated by mammalian 
isoforms have also been identified, including lipoxins (Serhan et al., 1984; Maderna & 
Gordon, 2009), resolvins (Serhan et al., 2004), protectins (Ariel et al., 2005; Schwab et al., 
2007) and maresins (Serhan et al., 2009). Therefore, LOX products play important roles in the 
development of acute inflammation but they have also been implicated in inflammatory 
resolution. (ii) Mice deficient in 12R-LOX develop normally during pregnancy but die 
immediately after birth due to excessive dehydration (Furstenberger et al., 2007; Epp et al., 
2007). Although the molecular mechanisms of postpartum mortality are unknown, the 
enzyme was implicated in the formation of the epidermal water barrier. Genetic 
polymorphisms of the corresponding human gene have been related to ichthyosis (Eckl et 
al., 2009), a disease characterized by dry, thickened, scaly or flaky skin (Ivanov et al., 2010). 
Available data also suggest that lipoxygenases contribute to in vivo metabolism of 
endobiotics and xenobiotics in mammals (Kulkarni, 2001). Recent reviews describe the role 
of lipoxygenase in cancer (Bhattacharya et al., 2009; Pidgeon et al., 2007; Moreno, 2009), 






et al., 2009; Mochizuki & Kwon, 2008) and for an extensive presentation of the role of 
eicosanoids in prevention and management of diseases the reader is referred to the review 
of Szefel et al. (2011). 
1.2 Quercetin  
Quercetin (3,3’,4’,5,7-pentahydroxyflavone) (Fig. 3) is an important dietary flavonoid, 
present in different vegetables, fruits, seeds, nuts, tea and red wine (Beecher et al., 1999; 
Formica, 1995; Hollman & Katan, 1999). 
 
Fig. 3. Chemical structure of quercetin. 
Quercetin has been discussed for several decades as a multipotent bioflavonoid with great 
potential for the prevention and treatment of disease (Bischoff, 2008). Its documented 
impact on human health includes cardiovascular protection, anticancer, antiviral, anti-
inflammatory activities, antiulcer effects and cataract prevention. The study of quercetin as 
potential chemopreventer is assuming increasing importance considering its involvement in 
the suppression of many tumor-related processes including oxidative stress, apoptosis, 
proliferation and metastasis. Quercetin has also received greater attention as pro-apoptotic 
flavonoid with a specific and almost exclusive activity on tumor cell lines rather than 
normal, non-transformed cells (Lugli et al., 2009).  
Among the biological effects of particular relevance, the antihypertensive effects of 
quercetin in humans and the improvement of endothelial function should also be 
emphasized (Bischoff, 2008). Together with its antithrombotic and anti-inflammatory effects, 
the latter mainly mediated through the inhibition of cytokines and nitric oxide, quercetin is 
a candidate for preventing obesity-related diseases (Bischoff, 2008). Most exciting findings 
are that quercetin enhances physical power by yet unclear mechanisms. The anti-infectious 
and immunomodulatory activities of quercetin might be related to this effect (Bischoff, 
2008). 
Like other flavonoids, quercetin appears to combine both lipoxygenase-inhibitory activities 
and free radical-scavenging properties in one agent and thus belongs to a family of very 
effective natural antioxidants (Sadik et al., 2003). Quercetin is a flavonol that can be easily 
oxidized in an aqueous environment, and in the presence of iron and hydroxyl free radicals 
(Borbulevych et al., 2004). More specifically, in an aqueous solution, quercetin is known to 
be oxidized to the relatively stable, neutral protocatechuate intermediate 2-(3,4-
dihydroxybenzoyl)-2,4,6-trihydroxybenzofuran-3(2H)-one (Fig. 5). This protocatechuate 
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derivative is a common oxidized intermediate mediated by various oxidases, such as 
lipoxygenase, tyrosinase (Kubo et al., 2004), and peroxidase (Awad et al., 2000), as well as by 
diphenylpicrylhydrazyl (DPPH) and azobisisobutyronitrile (AIBN) (Krishnamachari et al., 
2002) and seems to be a key intermediate to understand quercetin’s diverse biological 
activities (Ha et al., 2010). 
1.3 LOX inhibition by quercetin  
Because of its unique capability of the direct catalysis the enzymatic lipid peroxidation, 15-
LOX-1 belongs to the endogenous prooxidants the action of which may be favored under 
conditions of oxidative stress (Schewe, 2002). Consequently, the inhibition of 15-LOX-1 may 
contribute to the universal antioxidant activities of dietary flavonoids (Sadik et al., 2003). 
Flavonoids appear to combine both lipoxygenase-inhibitory activities and free radical-
scavenging properties in one agent and thus constitute a family of very effective natural 
antioxidants (Sadik et al., 2003). The literature data indicate that quercetin represents one of 
the most potent inhibitors of different LOXs (Schneider & Bucara, 2005; Schneider & Bucarb, 
2005).  
The inhibition of rabbit 15-LOX-1 and of soybean LOX-1 by quercetin was studied in detail 
(Sadik et al., 2003). Quercetin modulates the time course of the lipoxygenase reaction in a 
complex manner by exerting three distinct effects: (i) prolongation of the kinetic lag period, 
(ii) instant decrease in the initial rate after the lag phase being overcome, (iii) time-
dependent inactivation of the enzyme during reaction, but not in the absence of substrate 
(Schewe & Sies, 2003). Competitive reversible and irreversible inhibition schemes, as well as 
inhibition via reduction of the enzyme-bound radical intermediate have been considered to 
explain the activity of polyphenolic compounds (Fiorucci et al., 2008). Moreover, 
heterogeneity in the interpretation of the experimental results of the inhibition processes, for 
example concerning kinetic data, prevents converging toward a general way of inhibition 
(Fiorucci et al., 2008). It may be supposed that the inactivation is due to combined action of 
quercetin and intermediates of the catalytic cycle on the active site of the enzyme (Sadik et 
al., 2003). In previous work, Redrejo-Rodriguez et al. (2004) reported by semiempirical 
studies that the interaction of quercetin with lipoxygenase is related to the spatial 
adaptation of the flavonoid to the hydrophobic cavity that constitutes the channel of access 
of substrate to the catalytic site. 
Structural analysis reveals that quercetin entrapped within LOX undergoes degradation and 
the resulting compound has been identified by X-ray analysis as protocatechuic acid (3,4-
dihydroxybenzoic acid) positioned near the iron site (Borbulevych et al., 2004).  
 
Fig. 4. Chemical structure of protocatechuic acid, the product of quercetin degradation by 






The finding that LOX can turn different compounds, like quercetin and epigallocatechin 
gallate, into simple catechol derivatives (with one aromatic ring only) might be of 
importance as an additional small piece of a “jigsaw puzzle” in the much bigger picture of 
drug metabolism. Their interactions with LOX can be more complicated than simply 
blocking the access to the enzyme’s active site (Borbulevych et al., 2004). Ha et al. (2010) 
have studied the inhibitory activity of protocatechuic acid and of dodecyl protocatechuate 
on soybean LOX-1 oxidizing linoleic acid. Their results show that the protocatechuate 
derivative, dodecyl protocatechuate, inhibited the enzymatic peroxidation of linoleic acid as 
a competitive inhibitor, but its parent compound, protocatechuic acid did not show any 
activity up to 200 M. In this way it was shown that the catechol moiety alone is not 
sufficient to elicit the inhibitory activity and that the hydrophobic dodecyl group is 
associated with inhibitory activity as it was also reported for dodecyl gallate (Ha & Kubo, 
2007; Ha et al., 2010). 
Fiorucci et al. (2008) report theoretical investigations concerning three binding modes 
between quercetin and LOX-3 enzyme. Thus O3, O7, and O4’ oxygen atoms have been 
considered to bind the iron center (Fiorucci et al., 2008). These specific interactions lead then, 
through electron transfer from the substrate to the cation, to semiquinone forms, and related 
tautomeric structures that are compatible with an addition of the triplet spin state dioxygen 
to the flavonol squeleton (Fiorucci et al., 2008). Among the three considered modes of 
binding, it appears that quercetin should be linked to the metal center via its 3-OH 
functional group. The most favorable term to the binding free energy is due to electrostatic 
interactions (Fiorucci et al., 2008). 
In their proposed mechanism of oxidative degradation of quercetin by soybean LOX-1, Ha 
et al. (2010) indicate that quercetin might first be oxidized to the corresponding o-quinone 
after the abstraction of 2 e- and 2 H+ from the OH groups at C3’ and C4’ (Jungbluth et al., 
2000). The enzymatically oxidized o-quinone might be subsequently isomerized to a p-
quinone methide type intermediate, followed by the addition of H2O at C2, yielding the 
relatively stable intermediate 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxybenzofuran-3(2H)-
one (Ha et al., 2010). This enzymatically-generated intermediate appears to be relatively 
stable, and hence, prolongs the inhibitory activity (Ha et al., 2010). The results indicate that 
the soybean LOX-1 generated intermediate of quercetin is the same as the DPPH (2,2-
diphenyl--picrylhydrazyl) generated intermediate, 2-(3,4-dihydroxybenzoyl)-2,4,6-
trihydroxybenzofuran-3(2H)-one (Krishnamachari et al., 2002). In addition, the same 
oxidized intermediate was also characterized as the relatively stable intermediate generated 
by mushroom tyrosinase (Ha et al., 2010). 
 
Fig. 5. Product of oxidative degradation of quercetin by soybean LOX-1 as proposed by Ha 
et al. (2010). 
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The studies on LOX and quercetin contribute to the understanding of biocatalytic properties 
of this enzyme and its role in the metabolism of this popular (as a medicinal remedy) 
flavonol and possibly other, similar compounds (Borbulevych et al., 2004). 
1.4 O-quinone formation during quercetin oxidation by LOX  
Because flavonoids, such as quercetin, and oxidases are present simultaneously in fruits and 
vegetables, the generation of quinoid derivatives in biological systems is plausible (Pinto & 
Macias, 2005). This process is of great relevance from a biological point of view, because the 
conversion of supposed beneficial antioxidants such as flavonoids to electrophilic 
prooxidants may constitute a possible toxicological risk (Boersma et al., 2000). 
On the other hand, it is to be noted that, in addition to dioxygenase activity, lipoxygenase, 
possesses a peroxidase activity toward a wide range of compounds (Gardner, 1991). 
Dioxygenase activity produces the insertion of oxygen into a polyunsaturated fatty acid 
containing a 1,4-cis,cis-pentadiene moiety, producing the corresponding lipid 
hydroperoxide. In the process, an intermediate peroxyl radical is generated. This 
compound, or the peroxide, supports the cooxidase activity of lipoxygenase toward a 
suitable electron donor, which is transformed into a radical (Pinto & Macias, 2005). The 
hydroperoxidase activity of LOX also can be observed in the presence of hydrogen peroxide 
instead of lipid hydroperoxide, being related to xenobiotic oxidation processes (Hover & 
Kulkarni, 2000; Santanoa et al., 2002; Santanob et al., 2002). In addition, it is known that a 
variety of phenolic compounds and flavonoids with antioxidant properties are inhibitors of 
lipoxygenase (Prasad et al., 2004). 
On the basis of the results obtained, Pinto & Macias (2005) concluded that in the presence of 
hydrogen peroxide or hydroperoxylinoleic acid, lipoxygenase produces a quinoid product 
as a result of the enzymatic oxidation (in the presence of hydrogen peroxide) or cooxidation 
(in the presence of linoleic acid) of quercetin (Pinto & Macias, 2005). 
During lipoxygenase catalysis enzyme-bound prooxidant intermediates such as fatty acid 
peroxyl radical (ROO) are formed (Schewe, 2002). It is tempting to speculate, therefore, that 
the flavonoids are co-oxidized in this system to a semi-quinone or quinone (with flavonoids 
containing a catechol B ring) or a phenoxy radical (with noncatechol flavonoids) which in 
turn may covalently bind to sulfhydryl or amino groups of the lipoxygenase, thus rendering 
its inhibition irreversible (Sadik et al., 2003). In the case of quercetin and other flavonols, the 
intermediate formation of corresponding quinone methides (Awad et al., 2001) may be 
involved (Sadik et al., 2003). 
Quercetin is considered an excellent free radical scavenging antioxidant owing to the high 
number of hydroxyl groups and conjugated  orbitals by which quercetin can donate 
electrons or hydrogen, and scavenge H2O2 and superoxide anion (O2-) (Heijnen et al., 2001). 
The reaction of quercetin with O2- leads to the generation of the semiquinone radical and 
H2O2 (Metodiewa et al., 1999). Quercetin also reacts with H2O2 in the presence of 
peroxidases, and thus it decreases H2O2 levels and protects cells against H2O2 damage; 
nevertheless, during the same process potentially harmful reactive oxidation products are 
also formed. The first oxidation product of quercetin is a semiquinone radical (Metodiewa et 
al., 1999). This radical is unstable and rapidly undergoes a second oxidation reaction that 






react with proteins, lipids and DNA, it is responsible for protein and DNA damage as well 
as lipid peroxidation. 
The oxidative decomposition of quercetin by hydroperoxidase activity of lipoxygenase has 
been reported, suggesting that in the presence of the lipoxygenase/H2O2 system quercetin is 
oxidized to a quinoid product. It is remarkable that this behavior is not shown by 
naringenin or resveratrol, other bioactive antioxidant phenolics, probably due to the 
different redox potentials of these compounds (Pinto & Macias, 2005). 
UV-Vis spectroscopy is a widespread and commonly used technique that has been 
successfully used for the determination of catalytic mechanism, including enzyme-
substrate/inhibitor interaction profiles. In this report, we used UV-Vis spectroscopy to help 
elucidate possible interacting/inhibitory effect of quercetin with soybean LOX-1, oxidizing 
or not the linoleic acid. The UV-Vis spectral analysis of the mixture quercetin and LOX-1 
and the kinetic parameters (Km and Vmax) of LOX-1-catalyzed oxidation of linoleic acid in the 
absence and presence of different quercetin concentrations revealed that: 
i. quercetin (max= 370 nm) was oxidized to a new compound having max= 321 nm by 
LOX-1 in absence of substrate. 
ii. a mixed inhibition occurred for quercetin concentrations in the range of 10~50 M. 
iii. at 100 M, the highest quercetin concentration tested, the Kmapp decreased by half while 
reaction rate increased indicative of a cooxidation of quercetin in addition to the LOX 
classical reaction illustrating the switch in quercetin’s role from inhibitor towards 
substrate. 
iv. quercetin concentration significantly affected its partitioning level as a substrate or an 
inhibitor of LOX. 
v. the ratio substrate:inhibitor might be a factor determining the type of inhibition 
observed in the case of lipoxygenase and quercetin interaction. 
2. Biochemical analysis of LOX interaction with quercetin  
2.1 UV-Vis spectroscopy 
When a sample of an unknown compound is exposed to light, certain functional groups 
within the molecule absorb light of different wavelengths. In UV/Visible Spectroscopy, the 
term chromophore is used to indicate a functional group that absorbs electromagnetic 
radiation, usually in the UV or visible region. The type of functional groups that absorb 
ultraviolet light can be conjugated species, such as alkenes, aromatics, etc., making 
UV/Visible spectroscopy useful for distinguishing conjugated dienes from conjugated 
trienes, and so forth (Perkampus, 1992). 
The reference beam in the spectrometer travels from the light source to the detector without 
interacting with the sample. The sample beam interacts with the sample exposing it to 
ultraviolet light of continuously changing wavelength. When the emitted wavelength 
corresponds to the energy level which promotes an electron to a higher molecular orbital, 
energy is absorbed. The detector records the ratio between reference and sample beam 
intensities (I0/I). At the wavelength where the sample absorbs a large amount of light, the 
detector receives a very weak sample beam. Once intensity data has been collected by the 
spectrometer, it is sent to the computer as a ratio of reference beam and sample beam 
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intensities. The computer determines at what wavelength the sample absorbed a large 
amount of ultraviolet light by scanning for the largest gap between the two beams 
(Perkampus, 1992).  
When a large gap between intensities is found, where the sample beam intensity is 
significantly weaker than the reference beam, the computer plots this wavelength as having 
the highest ultraviolet light absorbance when it prepares the ultraviolet absorbance 
spectrum. Once the spectrometer has collected data from sample exposure to the UV beam, 
the data is transmitted to an attached computer which processes the intensity/wavelength 
data to produce an absorbance spectrum (Perkampus, 1992). 
Various techniques have been devised for the determination of lipoxidase activity, including 
colorimetric, polarographic and spectrophotometric methods (Holman, 1955). Firstly, the 
spectrophotometric method was developed after Holman and Burr (1945) and Bergström 
(1946). They had independently observed an increase in ultraviolet light absorption, at 234 
nm, when lipoxidase acted upon essential fatty acids. The increase in UV-peak absorption 
was then related to the amount of peroxide formation which, was found to be proportional 
to time and to enzyme concentration (Tappel, 1962; Theorell et al., 1944). The 
polyunsaturated fatty acid is solubilized by the addition of a detergent, and with this 
soluble substrate the activities of purified and crude lipoxidase are demonstrated over a 
wide range of pH (Tappel, 1962). 
In the ‘50s the research done for the elucidation of lipoxygenase activity was strongly linked 
to the UV-Vis spectrometry and until today the UV-Vis spectrometry is an essential tool in 
probing the lipoxygenase activity. Thus in 1952 in an article published in the Journal of 
Biological Chemistry, Tappel et al. (1952), using a Beckman DU quartz spectrophotometer 
that was equipped with a temperature-controlled cell compartment, showed that with 
sodium linoleate as a substrate, under suitable conditions the reaction velocity was linear 
with respect to the enzyme concentration and the reaction did not show an induction 
period. With methyl linoleate the reaction velocity was not directly proportional to enzyme 
concentration unless a Tween preparation was added.  
Antioxidants inhibited linoleate oxidation as a result of a direct effect on lipoxidase and of a 
preferential oxidation of the antioxidant. Rapid oxidation of nordihydroguaiaretic acid 
under suitable conditions was obtained in the absence of net linoleate oxidation, the 
linoleate having a function analogous to that of a coenzyme (Tappel et al., 1952).  
The inactivation of soybean lipoxygenase during oxygenation of fatty acid substrates was 
first described by Theorell et al. (1944). It was shown that velocity of the lipoxygenase-
catalyzed reaction decreases as a linear function of substrate utilization with all substrates 
tested.  
2.2 UV-Vis spectra of LOX reaction with quercetin  
We demonstrated by UV-Vis spectroscopy that pH values may influence the molecular 
interactions between soybean LOX-1 and quercetin, and especially the alkaline pH favors 
the ionic display of quercetin in order to interact with LOX better (Chedea et al., 2006). After 
60 min of incubation of soybean LOX and quercetin (50 M) the UV-Vis spectra showed the 
formation of a new product (max = 321 nm) indicating the formation of an intermolecular 







Fig. 6. The absorption spectra of the mixture soybean LOX-1 and quercetin (50 M) at the 
initial moment (min 0), blue line, and after 60 min of incubation, green line. For 
measurements 160 l standard LOX-1 (2300 enzymatic units/ml) and quercetin to the final 
concentration of 50 M were added to 790 l 0.2 M phosphate buffer pH 9. The spectra were 
registered on a Jasco-V 500 spectrophotometer and the blank contained 950 l buffer and 50 
l ethanol (Chedea et al., 2006).  
Fig. 6 shows the spectra of the mixture of LOX and quercetin. Three peaks (1, 2, 3) registered 
at t=0 and t=60 min of incubation were identified. Peak 1 corresponds to Band II, peak 3 to 
Band I, both bands characteristic for flavonoids, while peak 2 indicated the formation of a 
new compound as the result of reaction between lipoxygenase and quercetin.  
In the spectral range of 240-450 nm, flavone and their hydroxy substituted derivatives show 
two main absorption bands commonly referred to as Band I (300-400 nm) and Band II (240-
280 nm) (Mabry et al., 1970). Band I is supposed to be associated with the light absorption of 
the cinnamoyl system (B+C ring), and Band II with the absorption of the benzoyl moiety 
formed by the A+C ring (Fig. 7) (Zsila et al., 2003).  
 
Fig. 7. Chemical structure of quercetin. Frame highlights the cinnamoyl part of the molecule 
(Zsila et al., 2003). 
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The results of Chedea et al. (2006) are confirmed by the study of Ha et al. (2010). They 
observed the decrease in the absorbance of the band centered at 272 and 386 nm with the 
concomitant increase in the absorbance at 330 nm, and the presence of two isosbestic points 
at 286 and 357 nm, respectively, which is also in agreement with the report of Takahama 
(Takahama, 1985), and the hypsochromic shift likely indicates that quercetin was oxidized 
(Ha et al., 2010). The absorbance at 385 nm mainly results from the n* transition, and 
hence, the shift may be caused by structural changes including the ketone moiety, besides 
the change of the catechol on the ring B to the corresponding -quinone (Ha et al., 2010). In 
the study of Pinto and Macias, when quercetin is incubated in the presence of lipoxygenase 
and linoleic acid, a decrease of the band centered at 375 nm is produced, together with a 
slight increase of absorbance in the region of 330-340 nm (Pinto & Macias, 2005). 
Lipoxygenase inhibition, as a result of intermolecular interaction between the enzyme and 
quercetin, is dependent on the quercetin’s concentration. As the concentration of inhibitor 
increases the formation of a new compound as a result of this reaction increases as well, 
showing that a greater concentration of quercetin determines a more intense interaction 
between lipoxygenase and inhibitor (Vicaş et al., 2006). Quercetin exhibited a dose-
dependent inhibitory effect, and the lipoxygenase-catalyzed oxidation of linoleic acid to 13-
HPOD was inhibited with an IC50 value of 4.8 ± 4 M (Ha et al., 2010). 
Pinto at al. (2011) have shown also the existence of the interaction between lipoxygenase and 
quercetin. They also investigated the formation of an intermolecular complex between 
quercetin and lipoxygenase (Pinto et al., 2011). The acting forces between lipoxygenase and 
quercetin include mainly hydrogen bond and van der Waals, electrostatic and hydrophobic 
forces (Pinto et al., 2011). 
2.3 Enzyme kinetics  
Enzyme kinetics is the investigation of how enzymes bind substrates and turn them into 
products. The rate data used in kinetic analyses are obtained from enzyme assays. In 1913 
Leonor Michaelis and Maud Menten proposed a quantitative theory of enzyme kinetics, 
which is referred to as Michaelis-Menten kinetics. Their work was further developed by G. 
E. Briggs and J. B. S. Haldane, who derived kinetic equations that are still widely used 
today.  
The major contribution of Michaelis and Menten was to think of enzyme reactions in two 
stages. In the first, the substrate binds reversibly to the enzyme, forming the enzyme-
substrate complex. This is sometimes called the Michaelis-Menten complex in their honor. 
The enzyme then catalyzes the chemical step in the reaction and releases the product 
(Rogers & Gibon, 2009). 
To find the maximum speed of an enzymatic reaction, the substrate concentration is 
increased until a constant rate of product formation is seen. Saturation happens because, as 
substrate concentration increases, more and more of the free enzyme is converted into the 
substrate-bound ES form. At the maximum velocity (Vmax) of the enzyme, all enzyme active 
sites are saturated with substrate, and the amount of ES complex is the same as the total 
amount of enzyme. 
However, Vmax is only one kinetic constant of enzymes. The amount of substrate needed to 






constant (Km), which is the substrate concentration required for an enzyme to reach one-half 
its maximum velocity. For finding the substrate concentration required for an enzyme to 
reach one-half its maximum velocity, the reaction speed is measured at different substrate 
concentrations. Each enzyme has a characteristic Km for a given substrate, and this can show 
how tight the binding of the substrate is to the enzyme (Rogers & Gibon, 2009). 
The effect of substrate concentration ([S]) on activity is usually expressed using a Michaelis-
Menten plot, such as the one shown below, and enzymes which generate such a plot are said 
to obey Michaelis-Menten kinetics. Michaelis-Menten plots show three distinct regions 
which correspond to reaction order. At low [S], the reaction accelerates as more substrate is 
added, reflecting first-order kinetics. At high [S], the concentration of enzyme becomes 
limiting, and additional substrate cannot accelerate the reaction. This situation is known as 
zero-order kinetics. Finally, there is a transition period between first order and zero order 
where kinetics are mixed (http://wiz2.pharm.wayne.edu/biochem/enz.html).  
 
 
Fig. 8. A Michaelis-Menten plot. 
If one draws a line across from the level (zero order) region of the plot to the Y-axis, this 
data point is Vmax, the maximum rate of reaction for a given concentration of enzyme. The 
second kinetic constant is also derived by drawing a line from the Y-axis at 1/2 Vmax to the 
curve, and then down to the X-axis. Each substrate will generate a unique Km and Vmax for a 
given enzymatic process.  
A standard equation used to express the kinetic constants under the Michaelis-Menten 
hypothesis is aptly called the Michaelis-Menten equation, and is shown below. Later, two 
other investigators rearranged this equation to generate a second useful equation, the 
Lineweaver-Burk equation, also shown below.  
Two things should be noticed about the Lineweaver-Burk equation: first, it is in the form y = 
mx + b, and as such, a plot of this equation will generate a straight line for enzymes obeying 
simple Michaelis Menten kinetics. In addition, the x and y values for the plot are both 
inverted, and as such, the plot is often referred to as the double reciprocal plot. The 
Lineweaver-Burk plot has two advantages over the Michaelis-Menten plot, in that it gives a 
more accurate estimate of Vmax, and it gives more accurate information about inhibition as  
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well. A typical Lineweaver-Burk plot appears below. Note that Vmax is derived from the y-
intercept, and Km can be derived either from the slope, or from extrapolating the line to the 
negative X-axis (http://wiz2.pharm.wayne.edu/biochem/enz.html).  
 
Fig. 9. A typical Lineweaver-Burk plot. 
2.3.1 Enzyme inhibition  
There are two main classes of enzyme inhibitors, reversible and irreversible, that are 
differentiated by the magnitude of their affinity for enzyme. Reversible enzyme inhibitors 
bind and dissociate with their enzyme in an equilibrium process. Irreversible inhibitors bind 
tightly to an enzyme to form an essentially permanent complex. Reversible inhibitors can be 
classified as competitive, mixed, or noncompetitive inhibitors. If the detailed mechanism of 
inhibition is known, then the classification can be made by identifying where on the enzyme 
the inhibitor binds, or the order with which it binds, relative to substrate. Alternatively, a 
determination of simple kinetic parameters can generally be used to classify the inhibitor 
(http://www.wiley.com/college/pratt/0471393878/student/animations/enzyme_inhibitio
n/index.html) 
2.3.1.1 Competitive inhibitors 
Competitive inhibitors compete with substrate for an enzyme’s active site, lowering the 
enzyme’s likelihood of binding substrate and slowing the observed reaction velocity. Kinetic 






inhibitor. Typical steady-state kinetic experiments can be performed where reaction velocity 
is measured in the presence of varying concentrations of substrate. If inhibitor is then 
added, and the data shows an increase in Km, yet the Vmax is unaffected, this is the signature 
of a competitive inhibitor (http://www.wiley.com/college/pratt/0471393878/student/ 
animations/enzyme_inhibition/index.html) 
2.3.1.2 Mixed inhibition  
A mixed inhibitor binds to a site on the enzyme and interferes with both apparent substrate 
affinity and catalytic turnover, thus affecting the observed Km for the enzyme-catalyzed 
reaction. Mixed inhibitors do not bind directly in the active site, and therefore do not block 
substrate binding, but instead bind at sites that can be proximal or distal from the active site. 
Mixed inhibitors can therefore bind to free enzyme prior to substrate, distorting the active 
site to a nonoptimal conformation for catalysis. The inhibitor-distorted active site has 
trouble converting the substrate to product before it dissociates, resulting in a lowered 
apparent substrate binding affinity. Steady-state experiments performed in the presence of a 
mixed inhibitor demonstrate an increase or decrease in KM, and a decrease in Vmax 
(http://www.wiley.com/college/pratt/0471393878/student/animations/enzyme_inhibitio
n/index.html)  
2.3.1.3 Noncompetitive inhibition  
Noncompetitive inhibition is a special case of mixed inhibition where the affinity of 
inhibitor for E and ES is the same. Steady-state experiments performed in the presence of a 
noncompetitive inhibitor demonstrate a decrease in Vmax, yet Km is unaffected 
(http://www.wiley.com/college/pratt/0471393878/student/animations/enzyme_inhibitio
n/index.html) 
2.4 The influence of pure quercetin on sodium linoleate oxidation by pure soybean 
LOX-1  
2.4.1 The influence of quercetin on the LOX-1 oxidation of sodium linoleate for 
different experimental protocols 
It is of great interest to check if the oxidative decomposition of quercetin by lipoxygenase is 
produced in the presence of linoleic acid. It is known that the hydroperoxidase activity of 
lipoxygenase produces the cooxidation of suitable electron donors in the presence of the 
hydroperoxides of linoleic or arachidonic acid, the natural substrates for this enzyme (Pinto 
& Macias, 2005). When linoleic acid is used as the substrate the primary LOX dioxygenation 
product obtained is (9Z,11Z,13S)-hydroperoxyoctadeca-9,11-dienoic acid (13-HPOD) 
(Grechkin, 1998).  
Dioxygenase activity of lipoxygenase was measured by recording the increase in absorbance 
at 234 nm (formation of 13-HPOD), the incubation mixture containing 50 l quercetin in 
ethanol to a final concentration of 100 M, 8.4 l sodium linoleate at different concentrations 
(2.2 mM, 4.39 mM, 6.6 mM and 20 mM) and 160 l lipoxygenase (2300 units/ml) in 782 l 
0.2 M borate buffer pH 9. The final substrate concentrations were 18.5 M, 36.9 M, 55.4 M 
respectively 168 M. The reaction components were mixed following three protocols as Fig. 
10 indicates. The differences between these protocols are given by the order in which the 
enzyme, the substrate and the inhibitor were mixed and the incubation time.  
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As already presented in section 2.2, lipoxygenase in the absence of linoleic acid interacts 
with quercetin, thus Protocol 1 was designed to establish how the inhibition of substrate 
oxidation occurs when LOX-1 is initially incubated with the inhibitor. On the hand, Protocol 
2 follows the classical way of LOX assay where the enzyme reacts with the substrate in the 
presence of quercetin. In the typical LOX reaction, the oxidation of the iron atom occurs with 
consumption of one molecule of fatty acid hydroperoxide (Zheng & Brash, 2010), therefore, 
the objective of the protocol was to explore the possibility of quercetin reacting with the 
LOX reaction product, the 13-hydroperoxide. Finally, the objective of Protocol 3 was to 
check for the existence of competition between the substrate and inhibitor in a reaction 
environment where both linoleic acid and quercetin-also oxidized by lipoxygenase-exist.  
 
 
Fig. 10. Schematic representation of experimental protocols (1,2,3). 
Fig. 11. presents comparatively the inhibitory effect of quercetin 100 M on the oxidation of 
sodium linoleate by LOX-1 using all 3 experimental protocols. The kinetic curves of the 
reaction in the presence of quercetin are compared with the one of lipoxygenase without 
inhibitor (red curve). 
It can be seen from Fig. 11 that the strongest inhibition is reached in the case of protocol 2 
(pink line) when the inhibitor was added after the incubation for 15 seconds of sodium 
linoleate 55.4 M with the enzyme. For protocol 1 the typical Michaelis-Menten kinetic plot 
shape was maintained like for the LOX reaction with substrate without inhibitor (Fig. 11 
blue curve vs. red plot). A different shape has the plot in the case of protocols 2 (pink line) 
and 3 (green line). At low substrate concentrations for both protocols, 2 and 3 (Fig. 11 curves 
green and pink), the kinetic plots start with a burst phase-a very fast increase of the reaction 
velocity. It follows a decrease which is fast in the case of protocol 3 (green curve) and slower 
in the case of protocol 2 (pink curve). For protocol 2 the kinetic curve continues with a slight 
increase (starting with 55.4 M concentration of substrate), which in our situation didn’t 
reach the plateau phase. In the case of protocol 3 a new increase of the reaction rate -not so 
high compared with the first burst- follows at substrate concentration between 36.9 M and 








Fig. 11. The inhibitory effect of quercetin on the lipoxygenase reaction according to protocol 
3- dark green line; to protocol 2- pink line; to protocol 1- blue line. The red curve represents 
the kinetic without quercetin. The reaction components, 782 l 0.2 M borate buffer, (pH = 
9.0), 160 l of LOX solution (2300 U enzyme/ml) 8.4 l of sodium linoleate, of different 
concentrations (2.2 mM, 4.39 mM, 6.6 mM and 20 mM) having the final substrate 
concentration in the reaction mixture of 18.5 M, 36.9 M, 55.4 M and 168 M) and 50 l 
quercetin in ethanol to the final concentration of 100 M were added and mixed as Fig. 10. 
presents. The absorption at 234 nm (A234) against the blank was recorded.  
When both the substrate and the inhibitor were mixed and left for few seconds and then 
LOX was added the kinetic curve (Fig. 11 protocol 3), the first phase of fast increase shows 
that the hydroperoxides are formed as oxidation product of the linoleic acid even though the 
quercetin is present in the reaction mixture for very low substrate concentrations. LOX is 
partially inhibited by the quercetin at 36.9 M substrate concentration but then, at higher 
concentrations of substrate the enzyme becomes active again, but not as much as in the case 
of very low substrate concentration. Rapid inhibition followed by time dependent 
inactivation of soybean LOX-1 was also observed by Sadik et al. when quercetin was added 
to the reaction set-up after the substrate (Sadik et al., 2003). 
When LOX was incubated with the substrate for 15 seconds and then the quercetin was 
added, the kinetic plot shows that LOX oxidizes the substrate having the highest product 
yield for very low substrate concentrations, that quercetin partially inhibits the reaction at 
linoleate concentrations between 30 M and 55 M.  
Careful examination of the three protocols leads to speculation the quercetin-based 
inhibition of the soybean LOX-1 oxidation of linoleic acid does not follow the typical 
competitive inhibition model under the experimental conditions used (comparatively, 
protocol 3 gave the lowest inhibition than the other protocols tested). In Protocol I, it was 
observed that the new compound, a LOX-1-catalyzed by-product of quercetin, effectively 
inhibited the linoleic acid’s oxidation. In the case where quercetin is added the last, the LOX 
reaction inhibition pattern suggested that at certain substrate concentrations (between 45 
M and 75 M) quercetin would react with the hydroperoxide responsible for the initiation 
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of the LOX cycle, and thus implying the possibility of the quercetin undergoing non-
enzymatic oxidation leading to the reaction inhibition.  
2.4.2 Determination of kinetic parameters Km and Vmax of soybean LOX-1 standard 
towards linoleic acid as substrate  
The kinetic parameters for LOX-1 oxidation of sodium linoleate were calculated as control 
values and compared with LOX-1 oxidation of sodium linoleate in the presence of different 
concentrations of quercetin. For the measurements of pure LOX activity, to 832 l 0.2 M 
borate buffer, (pH = 9.0), 160 l of LOX solution (2300 U enzyme/ml) and 8.4 l of sodium 
linoleate of different concentrations (2.2 mM, 4.39 mM, 6.6 mM and 20 mM), having the final 
substrate concentration in the reaction mixture of 18.5 M, 36.9 M, 55.4 M and 168 M, 
were added. The absorption at 234 nm (A234) against the blank was recorded. The blank 
contained a mixture of 840 l 0.2 M borate buffer, (pH = 9.0) and 160 l of LOX solution 
(2300 U enzyme/ml). In order to obtain the Lineweaver-Burk plot, the v, 1/[S] and 1/v were 
calculated for different substrate concentrations (from 18.5- 168 M).  
 
Fig. 12. Michaelis-Menten plot (A) and Lineweaver-Burk plot (B) for different sodium 
linoleate concentrations oxidized by standard LOX-1. For the measurements of pure LOX 
activity, to 832 l 0.2 M borate buffer, (pH = 9.0), 160 l of LOX solution (2300 U 
enzyme/ml) and 8.4 l of sodium linoleate of different concentrations (2.2 mM, 4.39 mM, 6.6 
mM and 20 mM), having the final substrate concentration in the reaction mixture of 18.5 M, 
36.9 M, 55.4 M and 168 M, were added. The absorption at 234 nm (A234) against the 
blank was recorded. The blank contained a mixture of 840 l 0.2 M borate buffer, (pH = 9.0) 
and 160 l of LOX solution (2300 U enzyme/ml) (Chedea et al., 2008). Excel program was 
used to draw the graphs.  
The kinetic parameters calculated for LOX-1 oxidizing sodium linoleate show that the 
enzyme has a great affinity towards substrate (Km = 1.1 M) and that its oxidation is fast as 
well (Vmax= 2.7 Ms-1).  
2.4.3 Kinetic parameters for LOX-1 oxidizing sodium linoleate in presence of different 
quercetin concentrations 
The reaction velocities in the case of this first protocol for the three quercetin concentrations 






the absorption measurements of pure LOX activity to 782 l 0.2 M borate buffer, (pH = 9.0), 
160 l of LOX solution (2300 U enzyme/ml) 50 l quercetin (10 M, 50 M and 100 M final 
concentrations) and 8.4 l of sodium linoleate of different concentrations (2.2 mM, 4.39 mM, 
6.6 mM and 20 mM), having the final substrate concentration in the reaction mixture of 18.5 
M, 36.9 M, 55.4 M and 168 M, were added. The absorption at 234 nm (A234) against the 
blank was recorded. The blank contained a mixture of 840 l 0.2 M borate buffer, (pH = 9.0) 
and 160 l of LOX solution (2300 U enzyme/ml). 
The inhibitory effect of quercetin at different concentrations (100, 50 and 10 M) is presented 





Fig. 13. Lipoxygenase inhibition by quercetin at different concentrations (10 M, 50 M and 
100 M). Protocol 1 (Fig. 10) was followed for measurements as indicated in the legend of 
Fig. 11. 
Plotting the reaction velocity in function of substrate concentration it can be seen that the 
classical Michaelis-Menten shape of the curve is not registered in the case of LOX reaction 
inhibition by quercetin at 50 M. For this reason, it was taken into calculation a larger range 
of substrate and quercetin concentration and for those the reaction velocity was calculated.  
The kinetic curves representing the reaction velocity of the sodium linoleate oxidation by 
LOX-1, in presence of different concentrations of quercetin (Fig. 13) show that quercetin has 
an inhibitory effect on lipoxygenase for all the concentrations tested. To obtain these results, 
the reaction components were mixed as protocol 1 indicates, the enzyme being incubated 
with quercetin for 5 minutes and then the substrate is added. From Fig. 14 it can be seen that 
none of the kinetic plots follows the classical Michaelis-Menten shape. To get more 
information about the quercetin inhibitory action on soybean LOX-1, the kinetic parameters 
were calculated. 
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Fig. 14. Kinetic plots of the sodium linoleate (336 M, 252 M, 168 M, 126 M, 84 M, 63 
M, 42 M, 21 M, 10.5 M and 5.25 M), oxidation by LOX-1, in presence of different 
concentrations of quercetin 10 M (A), 25 M (B), 50 M (C) and 100 M (D).  
Fig. 14 indicates different behaviours of LOX-1 quercetin inhibition determined by the 
substrate’s and inhibitor’s concentrations. For quercetin at 100 M (Fig. 14D), 50 M (Fig. 
14C), at low concentrations of substrate (up to 21 M a fast increase of the reaction velocity 
is recorded, followed by a slight decrease and increase again (concentration of substrate 
between 21 M and 42 M). This “oscillatory” behaviour continues at higher substrate 
concentrations in the case of quercetin at 100 M and 50 M with a tendency of increasing 
the reaction’s velocity at concentrations of substrate higher than 336 M for 100 M 
quercetin and of reaching the plateau phase for 50 M quercetin.  
A fast decrease followed by an increase until the maximum velocity, characterises the 
kinetic plot of LOX-1 oxidizing the sodium linoleate at low substrate concentrations up to 84 
M (Fig. 14B) in the presence of quercetin 25 M. At this concentration of substrate (84 M) 
the reaction velocity reaches its maximum. It follows a significant decrease of the reaction 
velocity at substrate concentrations between 84 M and 134.4 M, the reaction rate 
increasing again and having the tendency to follow the classical Michael-Menten kinetic 
shape till at 252 M, substrate’s concentration. At this point a slight decrease of the reaction 
rate is registered, showing that for quercetin 25 M the inhibition is given by the high 
substrate concentration as well, when the sodium linoleate has a concentration higher than 
252 M (Fig. 14B). The same behaviour is registered in the case of quercetin 10 M at 






follows the tendency of the classical Michaelis-Menten shape, with a slight decrease in 
reaction velocity at concentrations of substrate between 63 M and 126 M.  
The observation that diminution of the degree of inhibition occurred by the decreasing of 
substrate concentration may imply that the substrate oxidation also plays a role in the 
process of LOX-1 inhibition by quercetin. This involvement may be one of the initial steps in 
the LOX inhibition, where quercetin is non-enzymatically oxidized by the reaction’s 
product, the hydroperoxide, resulting in the formation of the quercetin o-quinone. Once the 
”activation” of quercetin through its oxidation is triggered, it can be assumed that the 
enzymatic inhibition would proceed via a quercetin oxidation product.  
Km, Kmapp and Vmax calculated from the Lineweaver-Burk plots, for LOX-1 oxidizing sodium 
linoleate in the absence and presence of quercetin at 10 M, 25 M, 50 M and 100 M are 







(Ms-1/s) Type of inhibition 
100 0.55 3.8 - 
50 0.83 2.4 mixed 
25 0.78 1.8 mixed 
10 261.78 0.5 mixed 
0 1.103 2.7  
Table 1. Km, Kmapp and Vmax calculated from the Lineweaver-Burk plots, for LOX-1 oxidizing 
sodium linoleate in the absence and presence of quercetin at 10 M, 25 M, 50 M and 100 
M. 
The determined Kmapp and Vmax show a mixed inhibition for quercetin concentrations in the 
range of 10-50 M. For 100 M the Kmapp is half decreased and the reaction rate increases, 
reaching its highest value.  
In a previous study LOX activity was measured spectrophotometrically at 234 nm using 15 
mU of enzyme in the presence of 100 M linoleic acid in 50 mM potassium phosphate 
buffer, pH 7.5. For each scan 2 l of quercetin solution was added to 3 mL lipoxygenase 
solution to give a final concentration in the range 0.8 to 4.0 M and an inhibitory effect 
concentration dependent was detected (Pinto et al., 2011). This effect shows the 
characteristics of a competitive mechanism as it was deduced from Lineweaver-Burk plot 
(Pinto et al., 2011). On the basis of the competitive inhibition detected, the interaction should 
be located near or at the catalytic site (Pinto et al., 2011). The results obtained from the 
evaluation of three dimensional florescence spectra suggest a conformational modification 
of the protein in the region of the coupling with quercetin (Pinto et al., 2011). 
The degree of inhibition was paradoxically diminished with decreasing substrate 
concentration which reveals an unusual mode of the inhibitory effect (Sadik et al., 2003). In 
this case, a competitive type of inhibition appears to be excluded (Sadik et al., 2003). The 
rabbit reticulocyte 15-LOX-1 samples were pre-incubated for 2 min at 20° with 10 M 
quercetin and the reactions were started by addition of 0.265 mM potassium linoleate and 
the formation of conjugated dienoic fatty acids was recorded spectrophotometrically at 234 
nm (Sadik et al., 2003). Ha et al. report that quercetin inhibited soybean LOX-1 in a non-
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classical manner. The progress curves of O2 consumption showed that quercetin inhibited 
soybean LOX-1 by a slow-binding inhibition mechanism (Ha et al., 2010). 
3. Conclusions  
The aim of this study was to show how a widespread analysis tool like UV-Vis spectroscopy 
shapes the enzyme inhibition research having as an example the lipoxygenase interaction 
with quercetin. Almost all therapeutic drugs are enzyme inhibitors, from old medicine box 
standards such as aspirin and penicillin to the newest compounds used to treat HIV 
infection. Understandably, enzyme kinetics plays an outstanding role in this effort to 
produce effective therapeutics, for kinetic studies can quantify the degree that inhibitors 
inactivate or slow down the targeted enzyme’s catalytic rate and describe its potential 
efficacy as a drug. 
Since its characterisation in 1947 lipoxygenase is strongly related to the UV-Vis spectrometry 
as a valuable tool for its activity assay. Due to its implications in food chemistry and 
medicine LOX inhibition attracted up to date, the interest of researchers in the field. A 
highly functionalized flavonoid, quercetin proves to be a potent inhibitor of lipoxygenase 
acting both as a substrate and a source of inhibition, quercetin seems to play an antinomic 
role (Fiorucci et al., 2008). The partitioning level between quercetin as a substrate or as an 
inhibitor is dependent on its concentration. Different reversible inhibition schemes 
(competitive, noncompetitive, or mixed) as well as inhibition via reduction of the enzyme-
bound radical intermediate have been considered to explain the activity of quercetin as LOX 
inhibitor. Moreover, heterogeneity in the interpretation of the experimental results of the 
inhibition processes, for example concerning kinetic data, prevents converging toward a 
general way of inhibition (Fiorucci et al., 2008). The ratio substrate:inhibitor might be a 
factor determining the type of inhibition observed in the case of lipoxygenase and quercetin 
interaction.  
In our present study the UV-Vis spectra show the oxidation of quercetin and the formation 
of a new compound. The absorption maximum of this new formed molecule is centered 
around max= 321 nm, different from quercetin (max= 370 nm), suggesting loss of -electron 
delocalisation, i.e. interruption of the quercetin B and C ring -bond extended conjugated 
system (Bors et al., 1990; Abou Samra et al., 2011). The determined KMapp and vmax show a 
mixed inhibition for quercetin concentrations in the range of 10-50 M. For the highest 
quercetin concentration tested, 100 M, the Kmapp decreased by half but the reaction rate 
increases which might indicate a cooxidation of quercetin besides the LOX classical reaction, 
proving the switch in quercetin role from inhibitor towards substrate. Recent literature data 
show that quercetin itself inhibits the LOX reaction and also its oxidation products are 
inhibitors of LOX oxidation. For instance, quercetin may first act as a lipoxygenase inhibitor 
by reducing the ferric form of the enzyme to an inactive ferrous form, and then, the oxidized 
metabolite becomes a more potent inhibitor (Ha et al., 2010). 
In our study, the Michaelis-Menten (M-M), Lineweaver-Burk kinetics and UV spectral 
analysis have detected both the mixed inhibition and cooxidation of quercetin during 
soybean LOX-1-mediated metabolism of polyunsaturated fatty acid, linoleic acid. Though 
not yet convincingly proven, the mechanisms underlying the distinct kinetic behaviors are, 






quercetin molecules and/or its intermediates and the active site of the enzymes. 
Furthermore, the atypical kinetics might be interpreted using the model of two or possibly 
more binding regions within the enzyme active site(s) for the quercetin and intermediates. 
The finding that LOX can turn different compounds, like quercetin and epigallocatechin 
gallate, into simple catechol derivatives (with one aromatic ring only) might be of 
importance as an additional small piece of a “jigsaw puzzle” in the much bigger picture of 
drug metabolism (Borbulevych et al., 2004). However, the interactions of these flavanols 
with LOX can be more complicated than simply blocking the access to the enzyme’s active 
site as observed in this study. Therefore, it warrants future endeavours to thoroughly 
understand thus reliably predict interaction mechanism between the LOX proteins and 
therapeutic agents at the molecular level. This will be important in fully understanding the 
exact role of lipoxygenase inhibition by quercetin in therapy targeting and possibly 
identifying new bioactive molecules which would be used as drugs.  
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